Delivery Order SPE2DB25D3201-SPE2DB25FNULD
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $6,094.78, to provide ARIMIDEX 1 MG TABLET 30S. The contract has an ultimate completion date of July 9, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,512.79 firm fixed price contract is for the delivery of ARIMIDEX 1 MG TABLET 30S. The contract has an ultimate completion date of June 18, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $45,925.36 contract is for the delivery of 4,567,937,962 units of the pharmaceutical product Arimidex 1 mg tablets. The contract has an ultimate completion date of April 17, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $43,998.95, is for the supply of ARIMIDEX 1 MG TABLET 30S, a prescription medication. The contract is a firm fixed-price delivery order, with a performance period ending on July 10, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ARIMIDEX 1 MG TABLET 30S, a pharmaceutical product, with a firm fixed price ceiling value of $29,866.36 and a period of performance through May 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,539.92 and is for the delivery of ARIMIDEX 1 MG TABLET 30S, a brand-name pharmaceutical product. The contract is a Firm Fixed Price delivery order with a period of performance through March 12, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,690.72, is for the delivery of 4,568,092,832 tablets of the prescription medication Arimidex (1 mg). The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,802.19 firm fixed-price delivery order is for the supply of ARIMIDEX 1 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $4,802.19 and an ultimate completion date of November 9, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- The Defense Logistics Agency awarded a $3,034.37 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Arimidex 1 mg on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed price contract represents a non-competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The place of performance is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Anastrozole 1 mg tablets. The $4,266.59 firm fixed-price contract has a performance period ending on September 2, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a broad range of pharmaceutical products...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNULDDelivery Order
This is a $22,432.41 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of ARIMIDEX 1 MG TABLET 30S, a pharmaceutical product, with a performance period through July 7, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, particularly the DLA. The company holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not designated as a set-aside contract, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.4k | 7/3/25 |